Goldman Sachs’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-110,000
Closed -$1.73M 6018
2022
Q3
$1.73M Hold
110,000
﹤0.01% 4090
2022
Q2
$2.77M Buy
+110,000
New +$3.29M ﹤0.01% 3750

Other funds holding CRNC

Goldman Sachs's CRNC Position: Q2 2026 in Review

Goldman Sachs increased its Cerence (CRNC) stake by 23% in Q2 2026, buying an estimated $2.47M and bringing the position to 1,342,253 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2895.

Goldman Sachs first reported a position in CRNC in Q4 2019 and has held it in 27 quarters since. The position peaked at $61.9M in Q2 2021. 196 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Goldman Sachs held 1,342,253 shares of Cerence worth $15.2M as of Q2 2026.
  • Goldman Sachs bought 251,654 Cerence shares in Q2 2026, an estimated $2.47M.
  • Cerence made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2895 holding.
  • Goldman Sachs first reported a position in Cerence in Q4 2019 and has held it in 27 quarters since.
  • Goldman Sachs's Cerence position peaked at $61.9M in Q2 2021.
  • 196 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.